Cargando…
Incorporating efficacy data from initial trials into subsequent evaluations: Application to vaccines against respiratory syncytial virus
BACKGROUND. When a randomized controlled trial fails to demonstrate statistically significant efficacy against the primary endpoint, a potentially costly new trial would need to be conducted to receive licensure. Incorporating data from previous trials might allow for the conduct of more efficient f...
Autores principales: | Warren, Joshua L., Sundaram, Maria, Pitzer, Virginia E., Omer, Saad B., Weinberger, Daniel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081417/ https://www.ncbi.nlm.nih.gov/pubmed/37034783 http://dx.doi.org/10.1101/2023.03.27.23287639 |
Ejemplares similares
-
Community factors associated with local epidemic timing of respiratory syncytial virus: A spatiotemporal modeling study
por: Zheng, Zhe, et al.
Publicado: (2021) -
Assessment and optimization of respiratory syncytial virus prophylaxis in Connecticut, 1996–2013
por: Artin, Ben, et al.
Publicado: (2021) -
Relative timing of respiratory syncytial virus epidemics in summer 2021 across the United States was similar to a typical winter season
por: Zheng, Zhe, et al.
Publicado: (2022) -
Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US
por: Zheng, Zhe, et al.
Publicado: (2021) -
Incorporating data from multiple endpoints in the analysis of clinical trials: example from RSV vaccines
por: Prunas, Ottavia, et al.
Publicado: (2023)